| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| CSF3 | EPO | ENSPPYP00000009519 | ENSPPYP00000019531 | Colony stimulating factor 3. | Erythropoietin; Hormone involved in the regulation of erythrocyte proliferation and differentiation and the maintenance of a physiological level of circulating erythrocyte mass. Binds to EPOR leading to EPOR dimerization and JAK2 activation thereby activating specific downstream effectors, including STAT1 and STAT3. Belongs to the EPO/TPO family. | 0.950 |
| CSF3 | IFNG | ENSPPYP00000009519 | ENSPPYP00000005405 | Colony stimulating factor 3. | Interferon gamma; Produced by lymphocytes activated by specific antigens or mitogens. IFN-gamma, in addition to having antiviral activity, has important immunoregulatory functions. It is a potent activator of macrophages, it has antiproliferative effects on transformed cells and it can potentiate the antiviral and antitumor effects of the type I interferons. | 0.679 |
| CSF3 | JAK2 | ENSPPYP00000009519 | ENSPPYP00000021551 | Colony stimulating factor 3. | Tyrosine-protein kinase JAK2; Non-receptor tyrosine kinase involved in various processes such as cell growth, development, differentiation or histone modifications. Mediates essential signaling events in both innate and adaptive immunity. In the cytoplasm, plays a pivotal role in signal transduction via its association with type I receptors such as growth hormone (GHR), prolactin (PRLR), leptin (LEPR), erythropoietin (EPOR), thrombopoietin (THPO); or type II receptors including IFN-alpha, IFN- beta, IFN-gamma and multiple interleukins. Following ligand-binding to cell surface receptors [...] | 0.872 |
| CSF3 | LEP | ENSPPYP00000009519 | ENSPPYP00000020162 | Colony stimulating factor 3. | Leptin; Key player in the regulation of energy balance and body weight control. Once released into the circulation, has central and peripheral effects by binding LEPR, found in many tissues, which results in the activation of several major signaling pathways. In the hypothalamus, acts as an appetite-regulating factor that induces a decrease in food intake and an increase in energy consumption by inducing anorexinogenic factors and suppressing orexigenic neuropeptides, also regulates bone mass and secretion of hypothalamo- pituitary-adrenal hormones. In the periphery, increases basal me [...] | 0.928 |
| CSF3 | LEPR | ENSPPYP00000009519 | ENSPPYP00000001479 | Colony stimulating factor 3. | Leptin receptor. | 0.682 |
| CSF3 | LOC100446663 | ENSPPYP00000009519 | ENSPPYP00000009590 | Colony stimulating factor 3. | CSHL1 isoform 3. | 0.906 |
| CSF3 | PRL | ENSPPYP00000009519 | ENSPPYP00000018197 | Colony stimulating factor 3. | PRL isoform 1. | 0.908 |
| CSF3 | THPO | ENSPPYP00000009519 | ENSPPYP00000016057 | Colony stimulating factor 3. | THPO isoform 1. | 0.957 |
| EPO | CSF3 | ENSPPYP00000019531 | ENSPPYP00000009519 | Erythropoietin; Hormone involved in the regulation of erythrocyte proliferation and differentiation and the maintenance of a physiological level of circulating erythrocyte mass. Binds to EPOR leading to EPOR dimerization and JAK2 activation thereby activating specific downstream effectors, including STAT1 and STAT3. Belongs to the EPO/TPO family. | Colony stimulating factor 3. | 0.950 |
| EPO | JAK2 | ENSPPYP00000019531 | ENSPPYP00000021551 | Erythropoietin; Hormone involved in the regulation of erythrocyte proliferation and differentiation and the maintenance of a physiological level of circulating erythrocyte mass. Binds to EPOR leading to EPOR dimerization and JAK2 activation thereby activating specific downstream effectors, including STAT1 and STAT3. Belongs to the EPO/TPO family. | Tyrosine-protein kinase JAK2; Non-receptor tyrosine kinase involved in various processes such as cell growth, development, differentiation or histone modifications. Mediates essential signaling events in both innate and adaptive immunity. In the cytoplasm, plays a pivotal role in signal transduction via its association with type I receptors such as growth hormone (GHR), prolactin (PRLR), leptin (LEPR), erythropoietin (EPOR), thrombopoietin (THPO); or type II receptors including IFN-alpha, IFN- beta, IFN-gamma and multiple interleukins. Following ligand-binding to cell surface receptors [...] | 0.869 |
| EPO | LEP | ENSPPYP00000019531 | ENSPPYP00000020162 | Erythropoietin; Hormone involved in the regulation of erythrocyte proliferation and differentiation and the maintenance of a physiological level of circulating erythrocyte mass. Binds to EPOR leading to EPOR dimerization and JAK2 activation thereby activating specific downstream effectors, including STAT1 and STAT3. Belongs to the EPO/TPO family. | Leptin; Key player in the regulation of energy balance and body weight control. Once released into the circulation, has central and peripheral effects by binding LEPR, found in many tissues, which results in the activation of several major signaling pathways. In the hypothalamus, acts as an appetite-regulating factor that induces a decrease in food intake and an increase in energy consumption by inducing anorexinogenic factors and suppressing orexigenic neuropeptides, also regulates bone mass and secretion of hypothalamo- pituitary-adrenal hormones. In the periphery, increases basal me [...] | 0.954 |
| EPO | LEPR | ENSPPYP00000019531 | ENSPPYP00000001479 | Erythropoietin; Hormone involved in the regulation of erythrocyte proliferation and differentiation and the maintenance of a physiological level of circulating erythrocyte mass. Binds to EPOR leading to EPOR dimerization and JAK2 activation thereby activating specific downstream effectors, including STAT1 and STAT3. Belongs to the EPO/TPO family. | Leptin receptor. | 0.686 |
| EPO | LOC100446663 | ENSPPYP00000019531 | ENSPPYP00000009590 | Erythropoietin; Hormone involved in the regulation of erythrocyte proliferation and differentiation and the maintenance of a physiological level of circulating erythrocyte mass. Binds to EPOR leading to EPOR dimerization and JAK2 activation thereby activating specific downstream effectors, including STAT1 and STAT3. Belongs to the EPO/TPO family. | CSHL1 isoform 3. | 0.913 |
| EPO | PRL | ENSPPYP00000019531 | ENSPPYP00000018197 | Erythropoietin; Hormone involved in the regulation of erythrocyte proliferation and differentiation and the maintenance of a physiological level of circulating erythrocyte mass. Binds to EPOR leading to EPOR dimerization and JAK2 activation thereby activating specific downstream effectors, including STAT1 and STAT3. Belongs to the EPO/TPO family. | PRL isoform 1. | 0.929 |
| EPO | THPO | ENSPPYP00000019531 | ENSPPYP00000016057 | Erythropoietin; Hormone involved in the regulation of erythrocyte proliferation and differentiation and the maintenance of a physiological level of circulating erythrocyte mass. Binds to EPOR leading to EPOR dimerization and JAK2 activation thereby activating specific downstream effectors, including STAT1 and STAT3. Belongs to the EPO/TPO family. | THPO isoform 1. | 0.954 |
| GCG | GHRL | ENSPPYP00000014379 | ENSPPYP00000015270 | GCG isoform 1. | Ghrelin and obestatin prepropeptide. | 0.915 |
| GCG | LEP | ENSPPYP00000014379 | ENSPPYP00000020162 | GCG isoform 1. | Leptin; Key player in the regulation of energy balance and body weight control. Once released into the circulation, has central and peripheral effects by binding LEPR, found in many tissues, which results in the activation of several major signaling pathways. In the hypothalamus, acts as an appetite-regulating factor that induces a decrease in food intake and an increase in energy consumption by inducing anorexinogenic factors and suppressing orexigenic neuropeptides, also regulates bone mass and secretion of hypothalamo- pituitary-adrenal hormones. In the periphery, increases basal me [...] | 0.896 |
| GCG | LEPR | ENSPPYP00000014379 | ENSPPYP00000001479 | GCG isoform 1. | Leptin receptor. | 0.588 |
| GCG | PRL | ENSPPYP00000014379 | ENSPPYP00000018197 | GCG isoform 1. | PRL isoform 1. | 0.474 |
| GHRL | GCG | ENSPPYP00000015270 | ENSPPYP00000014379 | Ghrelin and obestatin prepropeptide. | GCG isoform 1. | 0.915 |